ArticleOncology reviews2020
Periocular basal cell carcinoma - clinical perspectives.
Article in Oncology reviews, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.
- Efficacy and safety of vismodegib in periocular and orbital basal cell carcinoma: a systematic review and meta-analysis.Frontiers in medicine · 2026Pooled it
- Clinical characteristics and prognostic factors associated with recurrence in periocular basal cell carcinoma in a Taiwanese population.Japanese journal of ophthalmology · 2026Article
- Intraoperative Margin Control in Eyelid Tumor Surgery: Current Standards, Imaging Advances, and Emerging Techniques.Current oncology (Toronto, Ont.) · 2026Review
- In Vivo Non-Invasive High-Resolution Imaging for the Evaluation of the Periocular Skin Area: A Comprehensive Review of the Literature.Journal of clinical medicine · 2026Review
- A Rare Case of Morpheaform Basal Cell Carcinoma With Lacrimal Sac Invasion.Case reports in surgery · 2026Article
- Clinical Outcomes and Prognostic Factors in Eyelid Malignancy: A 17-Year Retrospective Analysis of Surgical Management and Reconstruction Techniques.Korean journal of ophthalmology : KJO · 2025Article
- Palliative Radiotherapy to Preserve Eyesight in a Recurrent, Difficult-to-Treat Basal Cell Carcinoma.Cureus · 2025Article
- Orbital Lesions: A bird's eye view of series of 2068 cases in 27 years in a tertiary care hospital in Pakistan.Pakistan journal of medical sciences · 2024Article
- Basal cell carcinoma appearing to emanate from the punctum.American journal of ophthalmology case reports · 2024Article
- Results of Mohs' Micrographic Surgery of Periocular Basal Cell Carcinoma: The Swedish Experience.Acta dermato-venereologica · 2024Article
- Diagnosis and treatment of malignant eyelid tumors.Die Ophthalmologie · 2024Review
- Advanced Periocular Basal Cell Carcinoma with Orbital Invasion: Update on Management and Treatment Advances.Journal of ophthalmology · 2024Article
- The Efficacy of Sonidegib in Treating Locally Advanced Basal Cell Carcinoma Involving the Periocular Area.Dermatology and therapy · 2023Article
- [Diagnosis and treatment of malignant eyelid tumors].Die Ophthalmologie · 2023Review
- The free bilamellar autograft (FBA) procedure: A comprehensive case series of an alternative surgical approach to reconstruction of large eyelid defects.Frontiers in surgery · 2023Article
- Nodular basal cell carcinoma masquerading as traumatic laceration.BMJ case reports · 2022Article
- Periocular basal cell carcinoma results and surgical outcome during a 5-year period in a larger Danish population.BMC ophthalmology · 2022Article
- Clinicopathological Analysis and Surgical Outcome of Eyelid Malignancies: A Study of 332 Cases.Journal of skin cancer · 2022Article
- Primary periocular basal cell carcinoma: recurrence, risk factors and follow-up.Anais brasileiros de dermatologiaArticle
- Impacts of climate change on ocular health: A scoping review.The journal of climate change and healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Basal cell carcinoma (BCC) as a non-melanoma skin cancer type is the most common malignant tumor throughout the world. The incidence is higher in age over 60. The intense of exposure to ultraviolet radiation is one of the known risk factors. Over 50% of BCC of the periocular region initially occur on the lower lid and inner angle. Literature review of treatment options for basal cell carcinoma, which consist of surgery, or combined techniques plus vismodegib, radiotherapy and imiquimod. The first consideration for treatment of periocular BCC is radical surgical excision using Mohs micrographic technique. Functional and esthetic outcome in patients are important after clear excisions and reconstruction should be carefully considered. Radical exenteration is considered in the case of orbital invasion of high-risk aggressive BCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.